BrainStorm announces completion of all dosing in NurOwn phase 3 clinical trial in ALS
The NurOwn technology platform (autologous Mesenchymal stem cells, MSC-NTF cells) represent a promising investigational therapeutic approach to targeting…
03 Jul 20
The NurOwn technology platform (autologous Mesenchymal stem cells, MSC-NTF cells) represent a promising investigational therapeutic approach to targeting…
11 Jun 20
About one-quarter of US adults suffer from frequent knee pain, which limits function, decreases mobility, impacts sleep and…
22 Jan 20
Soin Neuroscience aims to continue to develop its spinal cord stimulation technology and expand into other types of…
09 Jan 20
The DTM spinal cord stimulation therapy is delivered through the Medtronic Intellis platform
19 Dec 19
Here we look in to smart utensils for people with Parkinson's disease to reduce their risk of falling…
18 Dec 19
Technology for social good start-ups specialising in energytech, healthtech and envirotech pitched their innovations at the Unbound London…
Patient Care DevicesPatient Care MonitoringDiagnostic Devices
12 Dec 19
Subscription models allow hospitals, health systems to upgrade critical systems while aligning costs with usage
06 Dec 19
The crux of Wave Neuroscience’s research revolves around the premise that the brain can be treated by non-pharmaceutical…
The implantable, long-lived, rechargeable, full-body MRI compatible Axonics r-SNM System was recently approved by the US Food &…
07 Nov 19
The new procedure marks a pivotal step in implementation of robotics to address neurovascular disease